GAVISCON MENTOL 250mg / 133.5mg / 80mg oral suspension in sachet medication leaflet

A02BX13 sodium alginate + sodium hydrogen carbonate + calcium carbonate • Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

The combination of sodium alginate, sodium bicarbonate (natrii hydrogeni carbonas), and calcium carbonate is used to treat symptoms of gastroesophageal reflux, such as heartburn and acid regurgitation. It works by forming a protective barrier in the stomach, preventing acid reflux into the esophagus.

Sodium alginate is a natural derivative from seaweed that, when in contact with stomach acid, forms a viscous gel. This gel floats on top of the stomach contents, acting as a physical barrier that prevents acid from reaching the esophagus.

Sodium bicarbonate helps neutralize stomach acid, providing rapid relief from heartburn. Additionally, the reaction between bicarbonate and stomach acid produces carbon dioxide, which helps lift the alginate gel, enhancing the effectiveness of the protective barrier.

Calcium carbonate also has an acid-neutralizing effect, providing additional relief from reflux symptoms. Furthermore, it contributes to strengthening the protective barrier formed by the alginate.

This combination is available as oral suspensions or chewable tablets and is usually taken after meals and before bedtime. It is important for patients to follow the doctor’s or package instructions to achieve maximum benefits.

Side effects are rare and include bloating, nausea, or constipation. In very rare cases, allergic reactions may occur. This combination is not recommended for patients with hypercalcemia, severe renal impairment, or allergies to any of the components. Patients should avoid excessive consumption of fatty or acidic foods, which can worsen reflux symptoms.

General data about GAVISCON MENTOL 250mg / 133.5mg / 80mg

Substance: sodium alginate + sodium hydrogen carbonate + calcium carbonate

Date of last drug list: 01-12-2022

Commercial code: W66098018

Concentration: 250mg / 133.5mg / 80mg

Pharmaceutical form: oral suspension in sachet

Quantity: 48

Product type: generic

Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

Manufacturer: RB NL BRANDS B.V. - OLANDA

Holder: RECKITT BENCKISER (ROMANIA) S.R.L. - ROMANIA

Number: 9077/2016/18

Shelf life: 2 years

Pharmaceutical forms available for sodium alginate + sodium hydrogen carbonate + calcium carbonate

Other substances similar to sodium alginate + sodium hydrogen carbonate + calcium carbonate